Comparable graft and patient survival in lean and obese liver transplant recipients

Liver Transplantation

Volumn 19, Issue 8, 2013, Pages 907-915

  Perez Protto, Silvia E ^a   Quintini, Cristiano ^a   Reynolds, Luke F ^b   You, Jing ^a   Cywinski, Jacek B ^a   Sessler, Daniel I ^a   Miller, Charles ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; LEAN BODY WEIGHT; LIVER GRAFT; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RETRANSPLANTATION; RETROSPECTIVE STUDY; SURGICAL MORTALITY;

EID: 84881110831     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23680     Document Type: Article

References (36)

1. Flegal KM, Carroll MD, Ogden CL, Curtin LR,. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
2. Pelletier SJ, Schaubel DE, Wei G, Englesbe MJ, Punch JD, Wolfe RA, et al. Effect of body mass index on the survival benefit of liver transplantation. Liver Transpl 2007; 13: 1678-1683.
3. Manson JE, Willett WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677-685.
4. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr,. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
5. Haslam DW, James WP,. Obesity. Lancet 2005; 366: 1197-1209.
6. Jiang J, Torok N,. Nonalcoholic steatohepatitis and the metabolic syndrome. Metab Syndr Relat Disord 2008; 6: 1-7.
7. Akinnusi ME, Pineda LA, El Solh AA,. Effect of obesity on intensive care morbidity and mortality: a meta-analysis. Crit Care Med 2008; 36: 151-158.
8. Schaeffer DF, Yoshida EM, Buczkowski AK, Chung SW, Steinbrecher UP, Erb SE, Scudamore CH,. Surgical morbidity in severely obese liver transplant recipients-a single Canadian centre experience. Ann Hepatol 2009; 8: 38-40.
9. Choban PS, Flancbaum L,. The impact of obesity on surgical outcomes: a review. J Am Coll Surg 1997; 185: 593-603.
10. Choban PS, Heckler R, Burge JC, Flancbaum L,. Increased incidence of nosocomial infections in obese surgical patients. Am Surg 1995; 61: 1001-1005.
11. Thuluvath PJ, Yoo HY, Thompson RE,. A model to predict survival at one month, one year, and five years after liver transplantation based on pretransplant clinical characteristics. Liver Transpl 2003; 9: 527-532.
12. Thuluvath PJ,. Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation. Liver Transpl 2007; 13: 1627-1629.
13. Fujikawa T, Fujita S, Mizuno S, Shenkman E, Vogel B, Lipori P, et al. Clinical and financial impact of obesity on the outcome of liver transplantation. Transplant Proc 2006; 38: 3612-3614.
14. Segev DL, Thompson RE, Locke JE, Simpkins CE, Thuluvath PJ, Montgomery RA, Maley WR,. Prolonged waiting times for liver transplantation in obese patients. Ann Surg 2008; 248: 863-870.
15. Rustgi VK, Marino G, Rustgi S, Halpern MT, Johnson LB, Tolleris C, Taddei TH,. Impact of body mass index on graft failure and overall survival following liver transplant. Clin Transplant 2004; 18: 634-637.
16. Kaplan EL, Meier P,. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
17. Cox DR,. Regression models and life-tables. J R Stat Soc Ser B 1972; 34: 187-220.
18. Curtis LH, Hammill BG, Eisenstein EL, Kramer JM, Anstrom KJ,. Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases. Med Care 2007; 45 (suppl 2): S103-S107.
19. Austin PC,. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009; 28: 3083-3107.
20. Agopian VG, Kaldas FM, Hong JC, Whittaker M, Holt C, Rana A, et al. Liver transplantation for nonalcoholic steatohepatitis: the new epidemic. Ann Surg 2012; 256: 624-633.
21. Sawyer RG, Pelletier SJ, Pruett TL,. Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation. Clin Transplant 1999; 13 (pt 2): 126-130.
22. Braunfeld MY, Chan S, Pregler J, Neelakanta G, Sopher MJ, Busuttil RW, Csete M,. Liver transplantation in the morbidly obese. J Clin Anesth 1996; 8: 585-590.
23. Keeffe EB, Gettys C, Esquivel CO,. Liver transplantation in patients with severe obesity. Transplantation 1994; 57: 309-311.
24. LaMattina JC, Foley DP, Fernandez LA, Pirsch JD, Musat AI, D'Alessandro AM, Mezrich JD,. Complications associated with liver transplantation in the obese recipient. Clin Transplant 2012; 26: 910-918.
25. Werneck M, Afonso RC, Coelho GR, Sboarini C, Coelho MP, Thomé T, et al. Obese and nonobese recipients had similar need for ventilatory support after liver transplantation. Transplant Proc 2011; 43: 165-169.
26. Boin IF, Almeida LV, Udo EY, Stucchi RS, Cardoso AR, Caruy CA, et al. Survival analysis of obese patients undergoing liver transplantation. Transplant Proc 2007; 39: 3225-3227.
27. Hillingsø JG, Wettergren A, Hyoudo M, Kirkegaard P,. Obesity increases mortality in liver transplantation-the Danish experience. Transpl Int 2005; 18: 1231-1235.
28. Nair S, Verma S, Thuluvath PJ,. Obesity and its effect on survival in patients undergoing orthotopic liver transplantation in the United States. Hepatology 2002; 35: 105-109.
29. Hakeem AR, Cockbain AJ, Raza SS, Pollard SG, Toogood GJ, Attia MA, et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl 2013; 19: 551-562.
30. Kallwitz ER,. Metabolic syndrome after liver transplantation: preventable illness or common consequence? World J Gastroenterol 2012; 18: 3627-3634.
31. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al.; for American Heart Association and National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005; 112: 2735-2752.
32. Hanouneh IA, Feldstein AE, McCullough AJ, Miller C, Aucejo F, Yerian L, et al. The significance of metabolic syndrome in the setting of recurrent hepatitis C after liver transplantation. Liver Transpl 2008; 14: 1287-1293.
33. Charlton M,. Obesity, hyperlipidemia, and metabolic syndrome. Liver Transpl 2009; 15 (suppl 2): S83-S89.
34. Hanouneh IA, Zein NN,. Metabolic syndrome and liver transplantation. Minerva Gastroenterol Dietol 2010; 56: 297-304.
35. Albeldawi M, Aggarwal A, Madhwal S, Cywinski J, Lopez R, Eghtesad B, Zein NN,. Cumulative risk of cardiovascular events after orthotopic liver transplantation. Liver Transpl 2012; 18: 370-375.
36. Pelletier SJ, Maraschio MA, Schaubel DE, Dykstra DM, Punch JD, Wolfe RA, et al. Survival benefit of kidney and liver transplantation for obese patients on the waiting list. Clin Transpl 2003: 77-88.